FHIRsmith: ValueSet/ValueSet-R3-v3-EntityNamePartQualifierR2-for-R5.json

FHIR IG analytics

Package	hl7.fhir.uv.xver-r3.r5
Resource Type	ValueSet
Id	ValueSet-R3-v3-EntityNamePartQualifierR2-for-R5.json
FHIR Version	R5
Source	http://hl7.org/fhir/uv/xver-r3.r5/0.0.1-snapshot-2/ValueSet-R3-v3-EntityNamePartQualifierR2-for-R5.html
URL	http://hl7.org/fhir/3.0/ValueSet/R3-v3-EntityNamePartQualifierR2-for-R5
Version	0.0.1-snapshot-2
Status	active
Date	2025-09-01T22:36:00.562646+10:00
Name	R3_v3_EntityNamePartQualifierR2_for_R5
Title	Cross-version VS for R3.v3 Code System EntityNamePartQualifierR2 for use in FHIR R5
Realm	uv
Authority	hl7
Description	This cross-version ValueSet represents concepts from http://hl7.org/fhir/ValueSet/v3-EntityNamePartQualifierR2\|2016-11-11 for use in FHIR R5. Concepts not present here have direct `equivalent` mappings crossing all versions from R3 to R5.

Resources that use this resource

No resources found

Resources that this resource uses

CodeSystem
EntityNamePartQualifierR2	v3-EntityNamePartQualifierR2

Narrative

Note: links and images are rebased to the (stated) source

Generated Narrative: ValueSet R3-v3-EntityNamePartQualifierR2-for-R5

This value set expansion contains 25 concepts.

Code	System	Display	Definition
SP	http://hl7.org/fhir/v3/EntityNamePartQualifierR2	spouse	Description:The name assumed from the partner in a marital relationship. Usually the spouse's family name. Note that no inference about gender can be made from the existence of spouse names.
AD	http://hl7.org/fhir/v3/EntityNamePartQualifierR2	acquired	Description:A name part a person acquired. The name part may be acquired by adoption, or the person may have chosen to use the name part for some other reason. `Note: this differs from an Other/Psuedonym/Alias in that an acquired name part is acquired on a formal basis rather than an informal one (e.g. registered as part of the official name).`
BR	http://hl7.org/fhir/v3/EntityNamePartQualifierR2	birth	Description:A name that a person was given at birth or established as a consequence of adoption. `Note: This is not used for temporary names assigned at birth such as "Baby of Smith" a" which is just a name with a use code of "TEMP".`
CL	http://hl7.org/fhir/v3/EntityNamePartQualifierR2	callme	Description:Used to indicate which of the various name parts is used when interacting with the person.
IN	http://hl7.org/fhir/v3/EntityNamePartQualifierR2	initial	Description:Indicates that a name part is just an initial. Initials do not imply a trailing period since this would not work with non-Latin scripts. In some languages, initials may consist of more than one letter, e.g., "Ph" could stand for "Philippe" or "Th" For "Thomas".
LS	http://hl7.org/fhir/v3/EntityNamePartQualifierR2	legal status	Description:For organizations a suffix indicating the legal status, e.g., "Inc.", "Co.", "AG", "GmbH", "B.V." "S.A.", "Ltd." etc.
MID	http://hl7.org/fhir/v3/EntityNamePartQualifierR2	middle name	Description:Indicates that the name part is a middle name. `Usage Notes: In general, the english "middle name" concept is all of the given names after the first. This qualifier may be used to explicitly indicate which given names are considered to be middle names. The middle name qualifier may also be used with family names. This is a Scandinavian use case, matching the concept of "mellomnavn","mellannamn". Note that there are specific rules that indicate what names may be taken as a mellannamn in different Scandinavian countries.`
PFX	http://hl7.org/fhir/v3/EntityNamePartQualifierR2	prefix	Description:A prefix has a strong association to the immediately following name part. A prefix has no implicit trailing white space (it has implicit leading white space though).
CON	http://hl7.org/fhir/v3/EntityNamePartQualifierR2	container name	Description: This refers to the container if present in the medicinal product name. `EXAMPLES: For Optaflu suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, prepared in cell culture) (2007/2008 season): pre-filled syringe`
DEV	http://hl7.org/fhir/v3/EntityNamePartQualifierR2	device name	Description: This refers to the qualifiers in the name for devices and is at the moment mainly applicable to insulins and inhalation products. `EXAMPLES: For the medicinal product Actrapid FlexPen 100 IU/ml Solution for injection Subcutaneous use: FlexPen.`
FLAV	http://hl7.org/fhir/v3/EntityNamePartQualifierR2	FlavorName	Description: This refers to a flavor of the medicinal product if present in the medicinal product name. `Examples: For 'CoughCure Linctus Orange Flavor', the flavor part is "Orange" For 'Wonderdrug Syrup Cherry Flavor', the flavor part is "Cherry"`
FORMUL	http://hl7.org/fhir/v3/EntityNamePartQualifierR2	FormulationPartName	Description: This refers to the formulation of the medicinal product if present in the medicinal product name. `Examples: For 'SpecialMed Sugar Free Cough Syrup', the formulation name part is "Sugar Free" For 'QuickCure Gluten-free Bulk Fibre', the formulation name part is "gluten-free"`
FRM	http://hl7.org/fhir/v3/EntityNamePartQualifierR2	form name	Description: This refers to the pharmaceutical form/ if present in the medicinal product name. `EXAMPLES: For Agenerase 50 mg soft capsules: Soft Capsules For Ludiomil 25mg-Filmtabletten: Filmtabletten For Optaflu suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, prepared in cell culture) (2007/2008 season): suspension for injection`
INV	http://hl7.org/fhir/v3/EntityNamePartQualifierR2	invented name	Description: This refers to the product name without the trademark or the name of the marketing authorization holder or any other descriptor reflected in the product name and, if appropriate, whether it is intended e.g. for babies, children or adults. `EXAMPLES: Agenerase Optaflu Ludiomil`
POPUL	http://hl7.org/fhir/v3/EntityNamePartQualifierR2	TargetPopulationName	Description: This refers to the target population for the medicinal product if present in the medicinal product name `Examples: For 'Broncho-Drug 3.5 mg-capsules for children', the target population part is "children" For 'Adult Chesty Cough Syrup', the target population part is "adult"`
SCI	http://hl7.org/fhir/v3/EntityNamePartQualifierR2	scientific name	Description: This refers to the product common or scientific name without the trademark or the name of the marketing authorization holder or any other descriptor reflected in the product name. `EXAMPLES: For Agenerase: N/A For Optaflu: Influenza vaccine (surface antigen, inactivated, prepared in cell culture) (2007/2008 season) For Ludiomil: N/A`
STR	http://hl7.org/fhir/v3/EntityNamePartQualifierR2	strength name	Description: This refers to the strength if present in the medicinal product name. The use of decimal points should be accommodated if required. `EXAMPLES: For Agenerase 50 mg soft capsules: 50mg For Ludiomil 25mg-Filmtabletten: 25 mg For Optaflu suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, prepared in cell culture) (2007/2008 season): N/A`
TIME	http://hl7.org/fhir/v3/EntityNamePartQualifierR2	TimeOrPeriodName	Description: This refers to a time or time period that may be specified in the text of the medicinal product name `Example: For an influenza vaccine 'Drug-FLU season 2008/2009', the time/period part is "2008/2009 season"`
TMK	http://hl7.org/fhir/v3/EntityNamePartQualifierR2	trademark name	Description: This refers to trademark/company element if present in the medicinal product name. `EXAMPLES: for Insulin Human Winthrop Comb 15: Winthrop`
USE	http://hl7.org/fhir/v3/EntityNamePartQualifierR2	intended use name	Description: This refers to the intended use if present in the medicinal product name without the trademark or the name of the marketing authorization holder or any other descriptor reflected in the product name. `Examples: For 'Drug-BI Caplets - Heartburn Relief', the intended use part is: "Heartburn Relief" For 'Medicine Honey Syrup for Soothing Coughs' the intended use part is "Soothing Coughs"`
SFX	http://hl7.org/fhir/v3/EntityNamePartQualifierR2	suffix	Description:A suffix has a strong association to the immediately preceding name part. A suffix has no implicit leading white space (it has implicit trailing white space though).
AC	http://hl7.org/fhir/v3/EntityNamePartQualifierR2	academic	Description:Indicates that a title like "Dr.", "M.D." or "Ph.D." is an academic title.
HON	http://hl7.org/fhir/v3/EntityNamePartQualifierR2	honorific	Description:A honorific such as "The Right Honourable" or "Weledelgeleerde Heer".
NB	http://hl7.org/fhir/v3/EntityNamePartQualifierR2	nobility	Description:A nobility title such as Sir, Count, Grafin.
PR	http://hl7.org/fhir/v3/EntityNamePartQualifierR2	professional	Description:Primarily in the British Imperial culture people tend to have an abbreviation of their professional organization as part of their credential titles.

Source1

{
  "resourceType": "ValueSet",
  "id": "R3-v3-EntityNamePartQualifierR2-for-R5",
  "text": {
    "status": "generated",
    "div": "<!-- snip (see above) -->"
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
      "valueInteger": 0
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
      "valueCode": "fhir"
    },
    {
      "extension": [
        {
          "url": "packageId",
          "valueId": "hl7.fhir.uv.xver-r3.r5"
        },
        {
          "url": "version",
          "valueString": "0.0.1-snapshot-2"
        }
      ],
      "url": "http://hl7.org/fhir/StructureDefinition/package-source"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status",
      "valueCode": "trial-use",
      "_valueCode": {
        "extension": [
          {
            "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
            "valueCanonical": "http://hl7.org/fhir/3.0/ImplementationGuide/hl7.fhir.uv.xver-r3.r5"
          }
        ]
      }
    }
  ],
  "url": "http://hl7.org/fhir/3.0/ValueSet/R3-v3-EntityNamePartQualifierR2-for-R5",
  "version": "0.0.1-snapshot-2",
  "name": "R3_v3_EntityNamePartQualifierR2_for_R5",
  "title": "Cross-version VS for R3.v3 Code System EntityNamePartQualifierR2 for use in FHIR R5",
  "status": "active",
  "experimental": false,
  "date": "2025-09-01T22:36:00.562646+10:00",
  "publisher": "FHIR Infrastructure",
  "contact": [
    {
      "name": "FHIR Infrastructure",
      "telecom": [
        {
          "system": "url",
          "value": "http://www.hl7.org/Special/committees/fiwg"
        }
      ]
    }
  ],
  "description": "This cross-version ValueSet represents concepts from http://hl7.org/fhir/ValueSet/v3-EntityNamePartQualifierR2|2016-11-11 for use in FHIR R5. Concepts not present here have direct `equivalent` mappings crossing all versions from R3 to R5.",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "http://unstats.un.org/unsd/methods/m49/m49.htm",
          "code": "001",
          "display": "World"
        }
      ]
    }
  ],
  "compose": {
    "include": [
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "concept": [
          {
            "code": "SP",
            "display": "spouse"
          },
          {
            "code": "AD",
            "display": "acquired"
          },
          {
            "code": "BR",
            "display": "birth"
          },
          {
            "code": "CL",
            "display": "callme"
          },
          {
            "code": "IN",
            "display": "initial"
          },
          {
            "code": "LS",
            "display": "legal status"
          },
          {
            "code": "MID",
            "display": "middle name"
          },
          {
            "code": "PFX",
            "display": "prefix"
          },
          {
            "code": "CON",
            "display": "container name"
          },
          {
            "code": "DEV",
            "display": "device name"
          },
          {
            "code": "FLAV",
            "display": "FlavorName"
          },
          {
            "code": "FORMUL",
            "display": "FormulationPartName"
          },
          {
            "code": "FRM",
            "display": "form name"
          },
          {
            "code": "INV",
            "display": "invented name"
          },
          {
            "code": "POPUL",
            "display": "TargetPopulationName"
          },
          {
            "code": "SCI",
            "display": "scientific name"
          },
          {
            "code": "STR",
            "display": "strength name"
          },
          {
            "code": "TIME",
            "display": "TimeOrPeriodName"
          },
          {
            "code": "TMK",
            "display": "trademark name"
          },
          {
            "code": "USE",
            "display": "intended use name"
          },
          {
            "code": "SFX",
            "display": "suffix"
          },
          {
            "code": "AC",
            "display": "academic"
          },
          {
            "code": "HON",
            "display": "honorific"
          },
          {
            "code": "NB",
            "display": "nobility"
          },
          {
            "code": "PR",
            "display": "professional"
          }
        ]
      }
    ]
  },
  "expansion": {
    "timestamp": "2025-09-01T22:36:00.560024+10:00",
    "contains": [
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "SP",
        "display": "spouse"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "AD",
        "display": "acquired"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "BR",
        "display": "birth"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "CL",
        "display": "callme"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "IN",
        "display": "initial"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "LS",
        "display": "legal status"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "MID",
        "display": "middle name"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "PFX",
        "display": "prefix"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "CON",
        "display": "container name"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "DEV",
        "display": "device name"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "FLAV",
        "display": "FlavorName"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "FORMUL",
        "display": "FormulationPartName"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "FRM",
        "display": "form name"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "INV",
        "display": "invented name"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "POPUL",
        "display": "TargetPopulationName"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "SCI",
        "display": "scientific name"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "STR",
        "display": "strength name"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "TIME",
        "display": "TimeOrPeriodName"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "TMK",
        "display": "trademark name"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "USE",
        "display": "intended use name"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "SFX",
        "display": "suffix"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "AC",
        "display": "academic"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "HON",
        "display": "honorific"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "NB",
        "display": "nobility"
      },
      {
        "system": "http://hl7.org/fhir/v3/EntityNamePartQualifierR2",
        "version": "2016-11-11",
        "code": "PR",
        "display": "professional"
      }
    ]
  }
}